Ladenburg Thalmann Financial Services’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-366	Closed	-$14K	–	4919
2015 Q2	$14K	Hold	366	–	–	﹤0.01%	3489
2015 Q1	$12K	Buy	366 +154	+73%	+$5.21K	﹤0.01%	3551
2014 Q4	$6K	Buy	212 +12	+6%	+$347	﹤0.01%	3704
2014 Q3	$6K	Hold	200	–	–	﹤0.01%	3370
2014 Q2	$6K	Buy	+200	New	+$5.52K	﹤0.01%	3351
2014 Q1	–	Sell	-557	Closed	-$14K	–	3965
2013 Q4	$14K	Hold	557	–	–	﹤0.01%	2759
2013 Q3	$17K	Buy	557 +118	+27%	+$3.28K	﹤0.01%	2577
2013 Q2	$13K	Buy	+439	New	+$12.1K	﹤0.01%	2600

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BRLI Position: Q3 2015 in Review

Ladenburg Thalmann Financial Services sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 366 shares — an estimated $14K sold.

Ladenburg Thalmann Financial Services first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $17K in Q3 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Ladenburg Thalmann Financial Services reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 366 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $14K.
Ladenburg Thalmann Financial Services first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
Ladenburg Thalmann Financial Services's BIO-REFERENCE LABS INC-NEW- position peaked at $17K in Q3 2013.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2015, filed 16 Nov 2015.